Table 1.
Control | WD | HESP | CAP | HESP + CAP | |
---|---|---|---|---|---|
Initial body weight (g) | 362 ± 16 | 353 ± 8 | 351 ± 15 | 356 ± 11 | 358 ± 15 |
Final body weight (g) | 428 ± 19 | 443 ± 14 | 433 ± 14 | 423 ± 15 | 433 ± 19 |
Body weight gain (3–5 months) (g) | 66 ± 7a | 91 ± 9b | 83 ± 4a,b | 67 ± 4a | 75 ± 8a,b |
Initial body fat (%) | 10.8 ± 0.7 | 10.8 ± 0.8 | 10.7 ± 0.7 | 10.9 ± 0.4 | 10.9 ± 0.8 |
Final body fat (%) | 11.5 ± 0.5a | 18.4 ± 1.5b | 15.9 ± 0.5b,c | 15.1 ± 0.4c | 15.9 ± 1.0b,c |
Liver (g) | 12.5 ± 0.7a | 14.6 ± 0.3b | 13.9 ± 0.5a,b | 13.0 ± 0.4a,c | 14.1 ± 0.5b,c |
Cumulative food intake (3–5 months) (Kcal) | 3970 ± 151a | 4683 ± 356b | 4431 ± 104a,b | 4337 ± 191a,b | 4351 ± 242a,b |
Initial and final body weight and body fat (before and at the end of treatment, respectively) are indicated. Data are mean ± SEM. One-way ANOVA was used to determine differences between groups followed by a least significance difference (LSD) post hoc analysis (P < 0.05), a ≠ b ≠ c.